Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Protara Therapeutics, Inc. (TARA) had Weighted-Average Shares Outstanding (Diluted) of 40.71M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-11.91M |
|
-- |
|
-- |
|
$14.12M |
|
$-14.12M |
|
$2.21M |
|
$-11.91M |
|
$-11.91M |
|
$-11.91M |
|
$-11.91M |
|
$-11.91M |
|
$-11.91M |
|
$-14.12M |
|
$-14.21M |
|
40.71M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
40.71M |
$-0.29 |
|
$-0.29 |
|
| Balance Sheet Financials | |
$126.53M |
|
$0.99M |
|
$42.03M |
|
$168.56M |
|
$7.02M |
|
-- |
|
$3.06M |
|
$10.07M |
|
$158.48M |
|
$158.48M |
|
$158.48M |
|
38.58M |
|
| Cash Flow Statement Financials | |
$-14.71M |
|
$-58.35M |
|
$1.73M |
|
$163.54M |
|
$92.21M |
|
$-71.34M |
|
$0.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.76M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.52% |
|
-7.52% |
|
-7.07% |
|
-7.52% |
|
$4.11 |
|
$-0.36 |
|
$-0.36 |
|